The application of X-ray crystallography and molecular modeling can provide valuable insight into the optimization of the molecular interactions of a drug-protein complex to achieve potency and selectivity of a drug candidate. For the successful application of SBDD in a drug development program, the impact of these structural modifications required to improve potency and selectivity must be considered in the context of balancing of a multitude of drug properties and other considerations that include solubility, bioavailability, metabolism, distribution, toxicology, chemical stability, and intellectual property space. The utility of structure-based design from the medicinal chemist's perspective is described in this chapter. © 2012 Springer Science+Business Media, LLC.
CITATION STYLE
Maddaford, S. P. (2012). A medicinal chemistry perspective on structure-based drug design and development. Methods in Molecular Biology, 841, 351–381. https://doi.org/10.1007/978-1-61779-520-6_15
Mendeley helps you to discover research relevant for your work.